Sunday, February 27, 2011

Using Monoclonal Antibodies to Treat Chikungunya

Two new fully human monoclonal antibodies have been discovered which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment (Togaviridae). They were developed by culturing immune cells isolated from an individual who had developed resistance to Chikungunya.

This shows a practical, modern application of the monoclonal antibody technique we were discussing earlier, developed from sendai virus (paramyxo). 

full article:

-Catalina Angel

No comments:

Post a Comment